VUMEDECO: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
VUMEDECO
Largest movements
- Receivables within one year -€58,191
down €58,191 (-63.2%), from €92,103 to €33,912
of which Other amounts receivable: -€70,191
- Cash -€17,624
down €17,624 (-94.6%), from €18,624 to €1,000
mainly Debts after one year (-€50,000) and Other debts (-€38,263)
- Debts after one year -€50,000
no longer reported in 2025 (was €50,000)
- Other debts -€38,263
down €38,263 (-94.3%), from €40,583 to €2,320
- Profit (loss) carried forward +€12,447
up €12,447 (+70.9%), from -€17,568 to -€5,121
- Gross operating margin +€45,557
up €45,557, from -€32,136 to €13,421
- Write-downs +€20,004
no longer reported in 2025 (was -€20,004)
- Financial charges -€3,206
down €3,206 (-96.2%), from €3,333 to €127
of which Non-recurring financial charges: -€3,021
- Financial income -€2,033
no longer reported in 2025 (was €2,033)
of which Non-recurring financial income: -€2,030
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €110,727 | €34,912 | -€75,815 | -68.5% |
| Current assets | 29/58 | €110,727 | €34,912 | -€75,815 | -68.5% |
| Amounts receivable within one year | 40/41 | €92,103 | €33,912 | -€58,191 | -63.2% |
| Trade receivables | 40 | €10,000 | €22,000 | +€12,000 | +120.0% |
| Other amounts receivable | 41 | €82,103 | €11,912 | -€70,191 | -85.5% |
| Cash at bank and in hand | 54/58 | €18,624 | €1,000 | -€17,624 | -94.6% |
| Total equity and liabilities | 10/49 | €110,727 | €34,912 | -€75,815 | -68.5% |
| Equity | 10/15 | €19,144 | €31,592 | +€12,447 | +65.0% |
| Contributions | 10/11 | €24,000 | €24,000 | = | 0.0% |
| Reserves | 13 | €12,712 | €12,712 | = | 0.0% |
| Non-distributable reserves | 130/1 | €450 | €450 | = | 0.0% |
| Reserves not available under the articles | 1311 | €450 | €450 | = | 0.0% |
| Tax-exempt reserves | 132 | €12,262 | €12,262 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€17,568 | -€5,121 | +€12,447 | +70.9% |
| Amounts payable | 17/49 | €91,583 | €3,320 | -€88,263 | -96.4% |
| Amounts payable after more than one year | 17 | €50,000 | - | -€50,000 | |
| Financial debts | 170/4 | €50,000 | - | -€50,000 | |
| Amounts payable within one year | 42/48 | €41,583 | €3,320 | -€38,263 | -92.0% |
| Trade debts | 44 | €1,000 | €1,000 | = | 0.0% |
| Suppliers | 440/4 | €1,000 | €1,000 | = | 0.0% |
| Other amounts payable | 47/48 | €40,583 | €2,320 | -€38,263 | -94.3% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€20,004 | - | +€20,004 | |
| Other operating charges | 640/8 | €846 | €846 | = | 0.0% |
| Gross operating margin | 9900 | -€32,136 | €13,421 | +€45,557 | |
| Operating profit (loss) | 9901 | -€12,979 | €12,574 | +€25,553 | |
| Financial income | 75/76B | €2,033 | - | -€2,033 | |
| Recurring financial income | 75 | €3 | - | -€3 | |
| Non-recurring financial income | 76B | €2,030 | - | -€2,030 | |
| Financial charges | 65/66B | €3,333 | €127 | -€3,206 | -96.2% |
| Recurring financial charges | 65 | €312 | €127 | -€185 | -59.3% |
| Non-recurring financial charges | 66B | €3,021 | - | -€3,021 | |
| Profit (loss) for the period before taxes | 9903 | -€14,279 | €12,447 | +€26,726 | |
| Income taxes | 67/77 | €312 | - | -€312 | |
| Profit (loss) for the period | 9904 | -€14,591 | €12,447 | +€27,038 | |
| Profit (loss) for the period to be appropriated | 9905 | -€14,591 | €12,447 | +€27,038 |
Source: filed annual accounts (NBB), fiscal years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.